RAIN · Categories · Form 4

RAIN - SEC Form 4 insider transactions

Rain Enhancement Technologies Holdco Inc. (RAIN) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for RAIN

• 13h
  Director Riley Christopher Michael was granted 50,000 shares (SEC Form 4)

  4 - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Issuer)
• 13h
  Director Sylvester David C was granted 40,000 shares (SEC Form 4)

  4 - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Issuer)
• 13h
  Director Steele Alexandra was granted 80,000 shares (SEC Form 4)

  4 - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Issuer)
• 13h
  Director Dickerson Lyman B was granted 80,000 shares, increasing direct ownership by 781% to 90,247 units (SEC Form 4)

  4 - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Issuer)
• 13h
  Director Reardon Robert was granted 80,000 shares (SEC Form 4)

  4 - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Issuer)
• 13h
  Interim CFO Truong Oanh was granted 50,000 shares (SEC Form 4)

  4 - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Issuer)
• 13h
  Director Peperzak Marcus was granted 80,000 shares (SEC Form 4)

  4 - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Issuer)
• 15h
  Director You Harry L. was granted 1,612,903 shares (SEC Form 4)

  4 - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Issuer)
• 265d
  Director Dickerson Lyman B sold $41,216 worth of shares (7,317 units at $5.63), decreasing direct ownership by 42% to 10,247 units (SEC Form 4)

  4 - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Issuer)
• 273d
  Chief Executive Officer Seidl Randy was granted 602,320 shares (SEC Form 4)

  4 - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Issuer)
• 494d
  Director You Harry L. was granted 43,910 shares (SEC Form 4)

  4 - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Issuer)
• 522d
  Director You Harry L. was granted 564,375 shares (SEC Form 4)

  4 - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Issuer)
• 525d
  Director Dickerson Lyman B was granted 17,564 shares (SEC Form 4)

  4 - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Issuer)
• 858d
  SEC Form 4 filed by Tang Kevin C

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 862d
  SEC Form 4 filed by Bvf Partners L P/Il

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 865d
  SEC Form 4 filed by Wolff Stefani

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 865d
  Radovich Peter closing all direct ownership in the company (SEC Form 4)

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 865d
  SEC Form 4 filed by Nguyen Tran

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 865d
  SEC Form 4 filed by Hrustanovic Gorjan

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 865d
  Davis Aaron I. closing all direct ownership in the company (SEC Form 4)

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 865d
  Berger Franklin M closing all direct ownership in the company (SEC Form 4)

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 865d
  SEC Form 4 filed by Atkisson Erik

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 865d
  Doebele Robert closing all direct ownership in the company (SEC Form 4)

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 865d
  Vellanki Avanish closing all direct ownership in the company (SEC Form 4)

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 904d
  Tang Kevin C sold $209,413 worth of shares (173,973 units at $1.20) (SEC Form 4)

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 1033d
  SEC Form 4 filed by Vellanki Avanish

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 1033d
  SEC Form 4 filed by Doebele Robert

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 1033d
  SEC Form 4 filed by Berger Franklin M

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 1033d
  SEC Form 4 filed by Radovich Peter

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 1033d
  SEC Form 4 filed by Nguyen Tran

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 1033d
  SEC Form 4 filed by Wolff Stefani

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 1033d
  SEC Form 4 filed by Hrustanovic Gorjan

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 1033d
  SEC Form 4 filed by Davis Aaron I.

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 1033d
  SEC Form 4 filed by Atkisson Erik

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 1033d
  SEC Form 4 filed by Bruce Josephine

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 1104d
  SEC Form 4 filed by Tang Kevin C

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 1112d
  SEC Form 4 filed by Boxer Capital, Llc

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 1208d
  SEC Form 4 filed by Cabatuan Nelson

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 1208d
  SEC Form 4 filed by Bryce Richard Paul

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 1208d
  SEC Form 4 filed by Doebele Robert

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 1208d
  SEC Form 4 filed by Vellanki Avanish

  4 - Rain Oncology Inc. (0001724979) (Issuer)
• 1294d
  SEC Form 4: Berger Franklin M bought $987,790 worth of shares (122,000 units at $8.10), increasing direct ownership by 14% to 1,005,207 units

  4 - Rain Therapeutics Inc. (0001724979) (Issuer)
• 1303d
  SEC Form 4: Berger Franklin M bought $249,996 worth of shares (42,881 units at $5.83), increasing direct ownership by 5% to 883,207 units

  4 - Rain Therapeutics Inc. (0001724979) (Issuer)
• 1307d
  SEC Form 4: Bvf Partners L P/Il bought $9,971,387 worth of Non-Voting Common Stock (1,710,358 units at $5.83)

  4 - Rain Therapeutics Inc. (0001724979) (Issuer)
• 1309d
  SEC Form 4: Davis Aaron I. bought $5,667,996 worth of shares (972,212 units at $5.83)

  4 - Rain Therapeutics Inc. (0001724979) (Issuer)
• 1390d
  SEC Form 4 filed by Berger Franklin M

  4 - Rain Therapeutics Inc. (0001724979) (Issuer)
• 1390d
  SEC Form 4 filed by Davis Aaron I.

  4 - Rain Therapeutics Inc. (0001724979) (Issuer)
• 1390d
  SEC Form 4 filed by Wolff Stefani

  4 - Rain Therapeutics Inc. (0001724979) (Issuer)
• 1390d
  SEC Form 4 filed by Nguyen Tran

  4 - Rain Therapeutics Inc. (0001724979) (Issuer)
• 1390d
  SEC Form 4 filed by Radovich Peter

  4 - Rain Therapeutics Inc. (0001724979) (Issuer)
• 1390d
  SEC Form 4 filed by Hrustanovic Gorjan

  4 - Rain Therapeutics Inc. (0001724979) (Issuer)
• 1433d
  SEC Form 4: Doebele Robert exercised 3,890 shares at a strike of $3.95, increasing direct ownership by 0.82% to 476,827 units

  4 - Rain Therapeutics Inc. (0001724979) (Issuer)
• 1468d
  SEC Form 4: Vellanki Avanish bought $57,250 worth of shares (25,000 units at $2.29), increasing direct ownership by 1% to 2,471,627 units

  4 - Rain Therapeutics Inc. (0001724979) (Issuer)
• 1516d
  SEC Form 4: Vellanki Avanish gifted 59,618 shares and received a gift of 59,618 shares, increasing direct ownership by 2% to 2,446,627 units

  4 - Rain Therapeutics Inc. (0001724979) (Issuer)
• 1516d
  SEC Form 4: Doebele Robert exercised 3,000 shares at a strike of $3.95, increasing direct ownership by 0.64% to 472,937 units

  4 - Rain Therapeutics Inc. (0001724979) (Issuer)
• 1527d
  SEC Form 4: Doebele Robert exercised 2,000 shares at a strike of $3.95, increasing direct ownership by 0.43% to 469,937 units

  4 - Rain Therapeutics Inc. (0001724979) (Issuer)
• 1547d
  SEC Form 4: Vellanki Avanish exercised 14,468 shares at a strike of $4.00, increasing direct ownership by 0.51% to 2,837,009 units

  4 - Rain Therapeutics Inc. (0001724979) (Issuer)
• 1586d
  SEC Form 4 filed by Cabatuan Nelson

  4 - Rain Therapeutics Inc. (0001724979) (Issuer)
• 1586d
  SEC Form 4 filed by Bryce Richard Paul

  4 - Rain Therapeutics Inc. (0001724979) (Issuer)
• 1586d
  SEC Form 4 filed by Vellanki Avanish

  4 - Rain Therapeutics Inc. (0001724979) (Issuer)

Other RAIN categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends